Researchers have discovered a link between prostate cancer aggressiveness and the accumulation of a compound produced when cholesterol is metabolized in cells, findings that could bring new diagnostic and treatment methods.Findings also suggest that a class of drugs previously developed to treat atherosclerosis might be repurposed for treatment of advanced prostate cancer.
Investigational drug may increase survival for some patients with advanced melanoma
3/06/2014
An experimental drug aimed at restoring the immune system's ability to spot and attack cancer halted cancer progression or shrank tumors in patients with advanced melanoma, according to a multisite, early-phase clinical trial at Johns Hopkins Kimmel Cancer Center and 11 other institutions.
Surgery over watchful waiting better for younger prostate cancer patients
3/06/2014
A new study in the New England Journal of Medicine finds that mortality rates are lower for younger men having surgery for prostate cancer, compared with those who follow watchful waiting.Prostate cancer is common among older men and rare in men under the age of 40.
Imprint of chemotherapy linked to inflammation in breast cancer survivors
3/06/2014
Many breast cancer survivors experience fatigue and other debilitating symptoms that persist months to years after their course of treatment has ended.Now researchers at the Winship Cancer Institute of Emory University have found clues that may explain how these symptoms can linger.
Some cancers evade detection by silencing parts of immune system cells
3/06/2014
Johns Hopkins researchers say they have identified a set of genes that appear to predict which tumors can evade detection by the body's immune system, a step that may enable them to eventually target only the patients most likely to respond best to a new class of treatment.
Researchers have discovered a link between prostate cancer aggressiveness and the accumulation of a compound produced when cholesterol is metabolized in cells, findings that could bring new diagnostic and treatment methods.Findings also suggest that a class of drugs previously developed to treat atherosclerosis might be repurposed for treatment of advanced prostate cancer.
Investigational drug may increase survival for some patients with advanced melanoma
3/06/2014
An experimental drug aimed at restoring the immune system's ability to spot and attack cancer halted cancer progression or shrank tumors in patients with advanced melanoma, according to a multisite, early-phase clinical trial at Johns Hopkins Kimmel Cancer Center and 11 other institutions.
Imprint of chemotherapy linked to inflammation in breast cancer survivors
3/06/2014
Many breast cancer survivors experience fatigue and other debilitating symptoms that persist months to years after their course of treatment has ended.Now researchers at the Winship Cancer Institute of Emory University have found clues that may explain how these symptoms can linger.
Some cancers evade detection by silencing parts of immune system cells
3/06/2014
Johns Hopkins researchers say they have identified a set of genes that appear to predict which tumors can evade detection by the body's immune system, a step that may enable them to eventually target only the patients most likely to respond best to a new class of treatment.
Colorectal cancer: the risk factors, symptoms and importance of screening
3/05/2014
According to the American Cancer Society, the lifetime risk of developing colorectal cancer is around 1 in 20. But according to a recent report from the Centers for Disease Control and Prevention, there are more than 20 million adults in the US who have never had the recommended screening for the disease, putting them at higher risk of dying from a preventable condition.